Overview

High Versus Low Dose of Caffeine for Apnea of Prematurity

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
0
Participant gender:
All
Summary
The optimum caffeine dose for apnea of prematurity has not been well investigated so the objective of the study is to compare high versus low dose of caffeine citrate to facilitate successful extubation in mechanically ventilated preterm infants.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mansoura University Children Hospital
Treatments:
Caffeine
Caffeine citrate
Criteria
Inclusion Criteria:

- newborn infant less than 32 weeks gestation with the diagnosis of apnea

Exclusion Criteria:

- newborn infants with gestational age more than 32 weeks.

- newborn infant with congenital malformations or chromosomal anomalies.